These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 17363371)
1. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer. Narita K; Chien J; Mullany SA; Staub J; Qian X; Lingle WL; Shridhar V J Biol Chem; 2007 May; 282(19):14413-20. PubMed ID: 17363371 [TBL] [Abstract][Full Text] [Related]
2. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. Lai J; Chien J; Staub J; Avula R; Greene EL; Matthews TA; Smith DI; Kaufmann SH; Roberts LR; Shridhar V J Biol Chem; 2003 Jun; 278(25):23107-17. PubMed ID: 12686563 [TBL] [Abstract][Full Text] [Related]
3. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174 [TBL] [Abstract][Full Text] [Related]
4. HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. Khurana A; Liu P; Mellone P; Lorenzon L; Vincenzi B; Datta K; Yang B; Linhardt RJ; Lingle W; Chien J; Baldi A; Shridhar V Cancer Res; 2011 Mar; 71(6):2152-61. PubMed ID: 21266348 [TBL] [Abstract][Full Text] [Related]
5. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo. Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125 [TBL] [Abstract][Full Text] [Related]
6. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Gilmore JL; Scott JA; Bouizar Z; Robling A; Pitfield SE; Riese DJ; Foley J Breast Cancer Res Treat; 2008 Aug; 110(3):493-505. PubMed ID: 17882547 [TBL] [Abstract][Full Text] [Related]
7. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. Willmarth NE; Ethier SP J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230 [TBL] [Abstract][Full Text] [Related]
8. Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Stiehl DP; Bordoli MR; Abreu-Rodríguez I; Wollenick K; Schraml P; Gradin K; Poellinger L; Kristiansen G; Wenger RH Oncogene; 2012 May; 31(18):2283-97. PubMed ID: 21927022 [TBL] [Abstract][Full Text] [Related]
9. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad. Nickerson NK; Mohammad KS; Gilmore JL; Crismore E; Bruzzaniti A; Guise TA; Foley J PLoS One; 2012; 7(1):e30255. PubMed ID: 22276166 [TBL] [Abstract][Full Text] [Related]
10. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels. Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394 [TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling. Cole CL; Rushton G; Jayson GC; Avizienyte E J Biol Chem; 2014 Apr; 289(15):10488-10501. PubMed ID: 24563483 [TBL] [Abstract][Full Text] [Related]
12. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439 [TBL] [Abstract][Full Text] [Related]
13. HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells. Zhang H; Newman DR; Sannes PL Respir Res; 2012 Aug; 13(1):69. PubMed ID: 22873647 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551 [TBL] [Abstract][Full Text] [Related]
15. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer. Baillo A; Giroux C; Ethier SP J Cell Physiol; 2011 Oct; 226(10):2691-701. PubMed ID: 21302279 [TBL] [Abstract][Full Text] [Related]
16. Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model. Xu G; Ji W; Su Y; Xu Y; Yan Y; Shen S; Li X; Sun B; Qian H; Chen L; Fu X; Wu M; Su C Oncotarget; 2014 Jul; 5(13):5029-39. PubMed ID: 24970807 [TBL] [Abstract][Full Text] [Related]
17. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Yotsumoto F; Yagi H; Suzuki SO; Oki E; Tsujioka H; Hachisuga T; Sonoda K; Kawarabayashi T; Mekada E; Miyamoto S Biochem Biophys Res Commun; 2008 Jan; 365(3):555-61. PubMed ID: 18023415 [TBL] [Abstract][Full Text] [Related]
18. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. Rittié L; Varani J; Kang S; Voorhees JJ; Fisher GJ J Invest Dermatol; 2006 Apr; 126(4):732-9. PubMed ID: 16470170 [TBL] [Abstract][Full Text] [Related]
19. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. Uchimura K; Morimoto-Tomita M; Bistrup A; Li J; Lyon M; Gallagher J; Werb Z; Rosen SD BMC Biochem; 2006 Jan; 7():2. PubMed ID: 16417632 [TBL] [Abstract][Full Text] [Related]
20. Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. Piepkorn M; Lo C; Plowman G J Cell Physiol; 1994 Apr; 159(1):114-20. PubMed ID: 8138579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]